IGF2 and cancer: In this regard, it is worth noting that IGF-II has been found to be able to bind and transduce signals via both the homo-tetrameric, high-affinity RTKs (IGF1R and IRA) and via its hetero-tetrameric (IGF1R/IRA) hybrid receptor in cancer [13].